VAERS reports by lot

Pfizer COVID-19 lot EWO162: VAERS reports

56 VAERS reports list lot EWO162 as a Pfizer COVID-19 vaccine, received between 2021-04-07 and 2024-05-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
56
Reports
14%
Marked serious
1
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5424%
Neurological4419%
Cardiac / Cardiovascular2511%
Musculoskeletal2410%
Gastrointestinal219%
Dermatological (non-injection-site)188%
Respiratory125%
Injection-site / Local reaction115%
Allergic / Anaphylactic73%
Thrombotic / Hematological63%
Reproductive / Menstrual52%
Autoimmune / Immune-mediated10%
Psychiatric / Neuropsychiatric10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York5
Michigan5
Florida5
Ohio5
Wisconsin4
New Jersey4
Virginia3
Utah3
Pennsylvania2
Missouri2
Texas2
Georgia2

Reports by month received

2021-0418
2021-0512
2021-063
2021-084
2021-094
2021-109
2021-111
2022-012
2022-062
2024-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.